What You Should Know:
– Reliant AI, a provider of generative AI-powered data analytics software, today announced its official launch and a significant $11.3M in seed funding round led by Tola Capital and Inovia Capital,…
Continue Reading
When the FDA approves a drug, passing that regulatory bar of safety and efficacy puts it on the path toward likely reimbursement by government and commercial payers. The same has not been true for…
Continue Reading
What You Should Know: – The healthcare venture capital landscape experienced a resurgence in the first half of 2024, according to a new report from Silicon Valley Bank (SVB). Despite ongoing economic challenges, 89%…
Continue Reading
Welcome to the July edition of Digital Health Digest!Dive into this month’s highlights, including strategic partnerships, significant funding rounds, and crucial IT disruptions in healthcare. Explore how these developments are driving innovation and addressing…
Continue Reading
Developments around AI in healthcare have accelerated in some ways since 2021 when we published our first eBook on the topic. Chatbots such as Chat GPT by OpenAI and generative AI are commonly used…
Continue Reading
Courier Health, a health tech company for life sciences manufacturers, announced it scored $16.5 million in Series A funding. Norwest Venture Partners led the round with participation from existing investor Work-Bench.
WHAT IT DOES
The New York-based…
What You Should Know: – Courier Health, a technology company transforming patient experiences in the life sciences industry raises $16.5M in Series A funding led by Norwest Venture Partners with participation from existing investor…
Continue Reading
What You Should Know:
– Pangea Biomed, a leader in precision oncology, announced a significant breakthrough in its ENLIGHT cancer response predictor. A new study published in Nature Cancer demonstrates the effectiveness of their ENLIGHT-DP…
Continue Reading
What You Should Know:
– A new report by Accenture, “Reinventing R&D in the Age of AI,” paints a clear picture: the biopharmaceutical industry stands at a critical juncture. Companies that embrace intelligent technologies like…
Continue Reading
Gameto, a biotechnology company, has raised $33 million in Series B funding, which it will use to support the clinical development of its in vitro maturation (IVM) product called Fertilo.
New York City-based Gameto develops…
Continue Reading
